Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Annals of Emergency Medicine|November 6, 2018
Use of a Rapid Diagnostic for Chlamydia trachomatis and Neisseria gonorrhoeae for Women in the Emergency Department Can Improve Clinical Management: Report of a Randomized Clinical TrialCharlotte A Gaydos, Michele-Corinne Ako, Mitra Lewis, et al.
Point of Care|September 25, 2018
Healthcare worker feedback on a prototype smartphone-based point-of-care test platform for use in episodic careDong Jin Shin, Mitra Lewis, Yu-Hsiang Hsieh, et al.
Contemporary Clinical Trials|March 18, 2026
Randomized controlled pilot trial of extended-release buprenorphine vs. sublingual buprenorphine-naloxone in rural settings (RXR): Study rationale and designLarissa J Mooney, Andrew J Saxon, Megan Black, et al.
Addiction (Abingdon, England)|January 11, 2021
Buprenorphine physician-pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials NetworkLi-Tzy Wu, William S John, Udi E Ghitza, et al.
Virus Evolution|May 27, 2021
Differential disease severity and whole-genome sequence analysis for human influenza A/H1N1pdm virus in 2015-2016 influenza seasonHsuan Liu, Yu-Nong Gong, Kathryn Shaw-Saliba, et al.
JAMA Network Open|May 22, 2023
Assessment of Screening Tools to Identify Substance Use Disorders Among AdolescentsSharon Levy, Melissa Brogna, Machiko Minegishi, et al.
Virus Evolution|June 16, 2021
Identification of H3N2 NA and PB1-F2 genetic variants and their association with disease symptoms during the 2014-15 influenza seasonDeena R Blumenkrantz, Thomas Mehoke, Kathryn Shaw-Saliba, et al.
Contemporary Clinical Trials|May 1, 2020
Medication treatment for opioid use disorder in expectant mothers (MOMs): Design considerations for a pragmatic randomized trial comparing extended-release and daily buprenorphine formulationsTheresa Winhusen, Michelle Lofwall, Hendrée E Jones, et al.
JAMA Internal Medicine|March 16, 2026
Extended-Release vs Sublingual Buprenorphine in Pregnancy Through 12 Months Post Partum: A Randomized Clinical TrialT John Winhusen, Michelle R Lofwall, Frankie Kropp, et al.
Pageof 1